100 related articles for article (PubMed ID: 28750810)
1. Purification of Functional CB
Fay JF; Farrens DL
Methods Enzymol; 2017; 593():343-370. PubMed ID: 28750810
[TBL] [Abstract][Full Text] [Related]
2. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
Fay JF; Farrens DL
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
[TBL] [Abstract][Full Text] [Related]
3. The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity.
Fay JF; Farrens DL
Biochemistry; 2013 Nov; 52(46):8286-94. PubMed ID: 24206272
[TBL] [Abstract][Full Text] [Related]
4. Purification and mass spectroscopic analysis of human CB1 cannabinoid receptor functionally expressed using the baculovirus system.
Xu W; Filppula SA; Mercier R; Yaddanapudi S; Pavlopoulos S; Cai J; Pierce WM; Makriyannis A
J Pept Res; 2005 Sep; 66(3):138-50. PubMed ID: 16083441
[TBL] [Abstract][Full Text] [Related]
5. Expression and characterization of human CB1 cannabinoid receptor in methylotrophic yeast Pichia pastoris.
Kim TK; Zhang R; Feng W; Cai J; Pierce W; Song ZH
Protein Expr Purif; 2005 Mar; 40(1):60-70. PubMed ID: 15721772
[TBL] [Abstract][Full Text] [Related]
6. A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor.
Tsukamoto H; Farrens DL
J Biol Chem; 2013 Sep; 288(39):28207-16. PubMed ID: 23940032
[TBL] [Abstract][Full Text] [Related]
7. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
Leo LM; Abood ME
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
[TBL] [Abstract][Full Text] [Related]
8. A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.
Fay JF; Farrens DL
J Biol Chem; 2012 Sep; 287(40):33873-82. PubMed ID: 22846992
[TBL] [Abstract][Full Text] [Related]
9. Structural Insights into CB1 Receptor Biased Signaling.
Al-Zoubi R; Morales P; Reggio PH
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
[TBL] [Abstract][Full Text] [Related]
10. Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.
McDonald NA; Henstridge CM; Connolly CN; Irving AJ
Mol Cell Neurosci; 2007 Jun; 35(2):237-48. PubMed ID: 17467290
[TBL] [Abstract][Full Text] [Related]
11. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
Janero DR; Korde A; Makriyannis A
Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
[TBL] [Abstract][Full Text] [Related]
12. Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein.
Farrens DL; Dunham TD; Fay JF; Dews IC; Caldwell J; Nauert B
J Pept Res; 2002 Dec; 60(6):336-47. PubMed ID: 12464112
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
Shim JY; Khurana L; Kendall DA
Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
[TBL] [Abstract][Full Text] [Related]
14. Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.
Iliff HA; Lynch DL; Kotsikorou E; Reggio PH
J Comput Chem; 2011 Jul; 32(10):2119-26. PubMed ID: 21523790
[TBL] [Abstract][Full Text] [Related]
15. Mammalian G protein-coupled receptor expression in Escherichia coli: II. Refolding and biophysical characterization of mouse cannabinoid receptor 1 and human parathyroid hormone receptor 1.
Michalke K; Huyghe C; Lichière J; Gravière ME; Siponen M; Sciara G; Lepaul I; Wagner R; Magg C; Rudolph R; Cambillau C; Desmyter A
Anal Biochem; 2010 Jun; 401(1):74-80. PubMed ID: 20175983
[TBL] [Abstract][Full Text] [Related]
16. Understanding functional residues of the cannabinoid CB1.
Shim JY
Curr Top Med Chem; 2010; 10(8):779-98. PubMed ID: 20370713
[TBL] [Abstract][Full Text] [Related]
17. High-throughput protein structural analysis using site-directed fluorescence labeling and the bimane derivative (2-pyridyl)dithiobimane.
Mansoor SE; Farrens DL
Biochemistry; 2004 Jul; 43(29):9426-38. PubMed ID: 15260485
[TBL] [Abstract][Full Text] [Related]
18. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.
Hryhorowicz S; Kaczmarek-Ryś M; Andrzejewska A; Staszak K; Hryhorowicz M; Korcz A; Słomski R
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771126
[TBL] [Abstract][Full Text] [Related]
19. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
Hudson BD; Hébert TE; Kelly ME
Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
[TBL] [Abstract][Full Text] [Related]
20. Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.
Montero C; Campillo NE; Goya P; Páez JA
Eur J Med Chem; 2005 Jan; 40(1):75-83. PubMed ID: 15642412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
